All In Biotech

Drug Trial Radar · NCT06697899

TGRX-678 Phase I Oral Pharmacokinetic Study

Food Effect on Pharmacokinetic Profile for TGRX-678 Tablet in Chinese Healthy Subject With Single Oral Administration

Last checked: Nov 19, 2026Latest source record: May 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

76

Actual

Start

Nov 24, 2024

Primary completion

Jan 6, 2025

Study completion Feb 20, 2025

Sponsor

Lead sponsor
Shenzhen TargetRx Co., Ltd.Industry
Sponsor type
Industry
Collaborators
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
First posted
Nov 20, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A study evaluating the effects of food intake on the pharmacokinetic (PK) profiles of TGRX-678

Conditions

  • Chronic Myeloid Leukemia

Interventions

  • TGRX-678Drug

    All participants are given TGRX-678 orally at 240 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Plasma TmaxTime frame: During Treatment period (Day 1 to Day 43)
  2. Plasma TlagTime frame: During Treatment period (Day 1 to Day 43)
  3. Plasma CmaxTime frame: During Treatment period (Day 1 to Day 43)
  4. Plasma AUC(0-t)Time frame: During Treatment period (Day 1 to Day 43)
  5. Plasma AUC(0-inf)Time frame: During Treatment period (Day 1 to Day 43)
  6. AUC(%Extrap)Time frame: During Treatment period (Day 1 to Day 43)
  7. Half Life (T1/2)Time frame: During Treatment period (Day 1 to Day 43)
  8. Plasma volume of distribution (Vz/F)Time frame: During Treatment period (Day 1 to Day 43)
  9. Plasma clearance (CL/F)Time frame: During Treatment period (Day 1 to Day 43)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.